
Reviva Pharmaceuticals Holdings, Inc. Warrants
RVPHW
RVPHW: Reviva Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, respiratory, and metabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, 1) Brilaroxazine (RP5063) which is in clinical development and is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and 2) RP1208.
moreShow RVPHW Financials
Recent trades of RVPHW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RVPHW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on RVPHW's company Twitter account
Number of mentions of RVPHW in WallStreetBets Daily Discussion
Recent insights relating to RVPHW
Recent picks made for RVPHW stock on CNBC
ETFs with the largest estimated holdings in RVPHW
Flights by private jets registered to RVPHW